Literature DB >> 2106335

Respiratory and sedative effects of clobazam and clonazepam in volunteers.

J D Wildin1, B J Pleuvry, G E Mawer, T Onon, L Millington.   

Abstract

1. The respiratory and psychomotor effects of two benzodiazepines used mainly as anticonvulsants were compared in healthy volunteers, using a double-blind placebo controlled design. 2. Clobazam (10 and 20 mg) produced significantly fewer psychomotor side effects than clonazepam (0.5 and 1 mg). Neither drug at either dose affected the ventilatory response to CO2. 3. Although clonazepam produced significant effects on psychomotor performance, these did not correlate with plasma drug concentration. 4. Our studies provide further evidence that at the doses chosen clobazam is considerably less sedating than clonazepam. Further investigation is required into the tolerance profile of both drugs in patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106335      PMCID: PMC1380080          DOI: 10.1111/j.1365-2125.1990.tb03616.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  12 in total

1.  Electron-capture GLC determination of clobazam and desmethylclobazam in plasma.

Authors:  D J Greenblatt
Journal:  J Pharm Sci       Date:  1980-11       Impact factor: 3.534

2.  Effect on postural sway of various benzodiazepine tranquillizers.

Authors:  A Patat; P Foulhoux
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

3.  Benzoctamine-a study of the respiratory effects of oral doses in human volunteers and interactions with morphine in mice.

Authors:  H J Utting; B J Pleuvry
Journal:  Br J Anaesth       Date:  1975-09       Impact factor: 9.166

4.  Depression of central respiratory drive by nitrazepam.

Authors:  M Rudolf; D M Geddes; J A Turner; K B Saunders
Journal:  Thorax       Date:  1978-02       Impact factor: 9.139

5.  Some aspects of the effects of clobazam on human psychomotor performance.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

6.  A clinical method for assessing the ventilatory response to carbon dioxide.

Authors:  D J Read
Journal:  Australas Ann Med       Date:  1967-02

7.  Intravenous clonazepam in the treatment of status epilepticus in children.

Authors:  P J Congdon; W I Forsythe
Journal:  Epilepsia       Date:  1980-02       Impact factor: 5.864

8.  Micro-determination of clonazepam in plasma or serum by electron-capture gas-liquid chromatography.

Authors:  N R Badcock; A C Pollard
Journal:  J Chromatogr       Date:  1982-07-09

9.  Pharmacokinetics of N-desmethylclobazam in healthy volunteers and patients with epilepsy.

Authors:  T Pullar; J R Haigh; S Peaker; M P Feely
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

10.  Respiratory and psychological effects of oral temazepam in volunteers.

Authors:  B J Pleuvry; S E Maddison; R B Odeh; M E Dodson
Journal:  Br J Anaesth       Date:  1980-09       Impact factor: 9.166

View more
  10 in total

Review 1.  GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam.

Authors:  Raman Sankar
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 2.  Perioperative substitution of anti-epileptic drugs.

Authors:  Wilma S W Wichards; Alfred F A M Schobben; Frans S S Leijten
Journal:  J Neurol       Date:  2013-09-01       Impact factor: 4.849

Review 3.  Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies.

Authors:  Jose de Leon; Edoardo Spina; Francisco J Diaz
Journal:  Ther Drug Monit       Date:  2013-02       Impact factor: 3.681

4.  Impairment of psychomotor function at modest plasma concentrations of carbamazepine after administration of the liquid suspension to naive subjects.

Authors:  J D Wildin; B J Pleuvry; G E Mawer
Journal:  Br J Clin Pharmacol       Date:  1993-01       Impact factor: 4.335

5.  Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.

Authors:  Andreas Siegenthaler; Jürg Schliessbach; Pascal H Vuilleumier; Peter Juni; Hanns U Zeilhofer; Lars Arendt-Nielsen; Michele Curatolo
Journal:  BMC Pharmacol Toxicol       Date:  2015-09-16       Impact factor: 2.483

6.  Effect of clobazam as add-on antiepileptic drug in patients with epilepsy.

Authors:  Rupa Joshi; Manjari Tripathi; Pooja Gupta; Yogendra Kumar Gupta
Journal:  Indian J Med Res       Date:  2014-08       Impact factor: 2.375

7.  Functional characterization of the 1,5-benzodiazepine clobazam and its major active metabolite N-desmethylclobazam at human GABA(A) receptors expressed in Xenopus laevis oocytes.

Authors:  Harriet Hammer; Bjarke Ebert; Henrik Sindal Jensen; Anders A Jensen
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

8.  Efficacy and Side Effect Profile of Clobazam in Children with Different Etiologies of Epilepsy from a Single Center.

Authors:  Tugce Aksu Uzunhan; Zeynep Gor
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2020-05-21

9.  Evaluation of anti-hyperalgesic and analgesic effects of two benzodiazepines in human experimental pain: a randomized placebo-controlled study.

Authors:  Pascal H Vuilleumier; Marie Besson; Jules Desmeules; Lars Arendt-Nielsen; Michele Curatolo
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

10.  Clobazam and its active metabolite N-desmethylclobazam display significantly greater affinities for α₂- versus α₁-GABA(A)-receptor complexes.

Authors:  Henrik Sindal Jensen; Kathryn Nichol; Deborah Lee; Bjarke Ebert
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.